论文部分内容阅读
应用人类绝经期促性腺激素(hMGs)可有效地诱发排卵,但常出现卵巢过度刺激和多发妊娠。近来提倡在用促性腺激素治疗阶段使用超声监测以预防这些合并症。有人提倡超声与血清雌二醇(E_2)水平同时,也有人认为用超声是估计卵泡成熟的唯一方法。为此,作者研究了卵泡功能与形态学的生长关系。对38名患者(平均年龄32.9±0.8岁)进行了38周期诱发排卵的指征是:多囊卵巢、无排卵、对克罗米芬无反应、宫颈因素及其它治疗无反应者。她们不孕期限1～14年(中位数2.8年)。诱发排卵是分段给予hMG和人类绒毛膜促性腺激素(hCG),注射时间是在得到血清E_2值结果后的下午。同时估价宫颈粘液量、粘稠度、羊齿状结晶、
Application of human menopausal gonadotropin (hMGs) can effectively induce ovulation, but often ovarian hyperstimulation and multiple pregnancies. It has recently been advocated to use ultrasound monitoring in the treatment of gonadotrophin to prevent these comorbidities. Some people advocate the ultrasound and serum estradiol (E2) levels, some people think that ultrasound is the only way to estimate follicular maturation. To this end, the author studied the relationship between follicular function and morphological growth. 38 patients (mean age 32.9 ± 0.8 years) were 38 cycles of induced ovulation indications are: polycystic ovary, anovulation, non-response to clomiphene, cervical factors and other non-responders. Their infertility period of 1 to 14 years (median 2.8 years). Ovulation induction is divided into hMG and human chorionic gonadotropin (hCG), injection time is in the afternoon after the results of serum E2 values. At the same time assess the amount of cervical mucus, viscosity, fermices,